Eko Foundation Analysis Software with Transformers (EFAST) vs Us2.ca

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Eko.Ai Pte Ltd. D/B/A Us2.Ai

AI Verdict

EFAST focuses on real-time AI analysis of auscultation data to detect structural murmurs and atrial fibrillation during routine exams. In contrast, Us2.ca specializes in fully automating the analysis of echocardiography data to generate comprehensive cardiac reports and detect various cardiac diseases. While both enhance cardiac diagnostics, EFAST is suited for initial screening with a stethoscope, whereas Us2.ca is designed for detailed post-echocardiogram analysis.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary need is real-time, AI-powered cardiac screening and early detection during routine physical examinations. This tool is ideal for clinicians who want immediate insights into structural murmurs and atrial fibrillation directly at the point of care, augmenting traditional auscultation with digital stethoscope integration and AI analysis. It streamlines early detection and provides actionable information during patient visits.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose Us2.ca if…

Choose Us2.ca if your focus is on fully automating and standardizing the analysis of echocardiography images to enhance diagnostic accuracy and workflow efficiency in the echo lab. This platform is best suited for cardiology departments and imaging centers seeking comprehensive, AI-generated cardiac reports with zero-click automation, covering a wide range of structural and functional parameters and disease indications from existing echo studies.

View Us2.ca →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) Us2.ca
Pricing Subscription-based, contact for details Contact for pricing
Deployment Cloud-based Software as a Medical Device (SaMD) Cloud, On-premise
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Us2.ca

Us2.ca emphasizes 'zero clicks' and fully automated echocardiography analysis, streamlining a complex workflow from DICOM upload to final report in seconds. While EFAST offers real-time analysis during auscultation, Us2.ca's comprehensive automation for echo interpretation appears to offer a higher degree of workflow efficiency and ease of use for its specific task.

Clinical Value

Us2.ca

Us2.ca provides comprehensive, automated echocardiography analysis for a wider range of conditions, including Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension, with detailed structural and functional parameters. EFAST focuses on structural murmur and AFib detection during auscultation, which is valuable for screening, but Us2.ca offers deeper diagnostic insights with extensive clinical validation.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers more transparency regarding its pricing model, stating it is subscription-based with an Eko+ membership and providing a daily cost estimate for its associated stethoscope technology. Us2.ca's pricing is not publicly disclosed, only mentioning a volume-based model that requires direct contact for details.

Enterprise Readiness

Us2.ca

Us2.ca offers both cloud and on-premise deployment options, which is crucial for enterprises with varying IT infrastructure and data residency requirements. It also boasts broader integration capabilities with ultrasound devices, PACS, CVIS, and EMR systems, along with SOC 2 Type II certification, making it more adaptable for large-scale deployments.

Innovation

Us2.ca

Us2.ca's 'zero-click' full automation of complex echocardiography analysis, including advanced features like vendor-neutral strain imaging and explainable AI, represents a significant innovation in transforming diagnostic workflows. While EFAST is innovative in bringing real-time AI to point-of-care auscultation, Us2.ca's comprehensive automation for a traditionally labor-intensive imaging modality pushes the boundaries further.

Support & Docs

Us2.ca

Us2.ca provides structured support for enterprise customers, including technical architecture reviews, compliance documentation, and deployment plans, with on-premise updates handled by their support. While Eko Health offers a Help Center, some user reviews indicate challenges with direct customer service responsiveness.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) Us2.ca
Name Eko Foundation Analysis Software with Transformers (EFAST) Us2.ca
Company Eko Health Eko.Ai Pte Ltd. D/B/A Us2.Ai
Description EFAST by Eko Health is an advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. Us2.ai is an FDA-cleared and CE-marked AI platform that fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports in seconds to enhance diagnostic accuracy and workflow efficiency.
Key Features AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation; Enhanced audio with noise cancellation and amplification; Waveform visualization and guided exams; Seamless integration with Eko digital stethoscopes (e.g., CORE 500); Cloud-based recording and secure storage of exams; EMR integration for streamlined documentation. Fully automated echocardiography analysis (zero clicks); Real-time processing and structured report generation; AI-powered disease detection (e.g., Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, Pulmonary Hypertension); Integration with ultrasound devices, PACS, CVIS, and EMR; Guideline-based measurements and disease indication conclusions; Explainable AI with editable annotations and visual overlays; Comprehensive cardiac structural and functional parameters (2D, Doppler, M-mode, strain imaging); Cloud and on-premise deployment options.
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and Us2.ca.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Foundation Analysis Software with Transformers (EFAST) analyzes real-time auscultation data from Eko digital stethoscopes to assist in identifying structural murmurs and detecting atrial fibrillation during routine exams. Us2.ai, on the other hand, fully automates the analysis of echocardiography images to deliver comprehensive, structured cardiac reports and detect various cardiac diseases.
EFAST is designed to assist clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation. Us2.ai offers AI-powered disease detection for conditions such as Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension, in addition to providing comprehensive cardiac structural and functional parameters.
EFAST seamlessly integrates with Eko digital stethoscopes and offers EMR integration for streamlined documentation. Us2.ai integrates with ultrasound devices, PACS, CVIS, and EMR systems, aiming to enhance diagnostic accuracy and workflow efficiency.
EFAST reports AI-powered structural murmur detection with 93% sensitivity and 91% specificity, and AI-powered atrial fibrillation (AFib) detection with 95% sensitivity and 94% specificity. The provided information for Us2.ai lists various diseases it detects but does not include specific sensitivity and specificity metrics in the given facts.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.